Cite

HARVARD Citation

    Gillman, J. et al. (2019). Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy. Journal of antimicrobial chemotherapy. pp. 2365-2369. [Online]. 
  
Back to record